Gene · 1629
Papers1,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,694
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features. | Cancer Rep (Hoboken) | 2023 | 37885090 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. | Sci Rep | 2023 | 37884650 | PubTator, text mining | PubMed |
| 2023 APHL/ISNS Newborn Screening Symposium. | Int J Neonatal Screen | 2023 | 37873845 | PubTator, text mining | PubMed |
| Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications. | J Transl Med | 2023 | 37864163 | PubTator, text mining | PubMed |
| A prognostic and immunotherapy effectiveness model for pancreatic adenocarcinoma based on cuproptosis-related lncRNAs signature. | Medicine (Baltimore) | 2023 | 37861553 | PubTator, text mining | PubMed |
| Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis. | Medicine (Baltimore) | 2023 | 37861502 | PubTator, text mining | PubMed |
| Is adherence to dialectic behaviour therapy for post-traumatic stress disorder (PTSD) and cognitive processing therapy related to treatment outcome in PTSD after childhood abuse? | Eur J Psychotraumatol | 2023 | 37860858 | PubTator, text mining | PubMed |
Coordination of Single-cell and Bulk RNA Sequencing to Construct a Cuproptosis-related Gene Prognostic Index for Endometrial Cancer Prognosis, Immune Microenvironment Infiltration, and Immunotherapy Treatment Options. | J Cancer | 2023 | 37859813 | PubTator, text mining | PubMed |
| CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model. | Aging (Albany NY) | 2023 | 37857018 | PubTator, text mining | PubMed |
| Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancer. | Sci Rep | 2023 | 37853210 | PubTator, text mining | PubMed |
| Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the Pathanamthitta District of Kerala. | JMIR Res Protoc | 2023 | 37843912 | PubTator, text mining | PubMed |
| Room temperature stable E,Z-diphosphenes: their isomerization, coordination, and cycloaddition chemistry. | Chem Sci | 2023 | 37829033 | PubTator, text mining | PubMed |
| DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. | Sci Rep | 2023 | 37828099 | PubTator, text mining | PubMed |
| Reactive nitrogen species inhibit branched chain alpha-ketoacid dehydrogenase complex and impact muscle cell metabolism. | J Biol Chem | 2023 | 37827290 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis. | Front Immunol | 2023 | 37809099 | PubTator, text mining | PubMed |
| Circadian clock crosstalks with autism. | Brain Behav | 2023 | 37807632 | PubTator, text mining | PubMed |
| Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. | MedComm (2020) | 2023 | 37799806 | PubTator, text mining | PubMed |
| Bioinformatics analysis of copper death gene in diabetic immune infiltration. | Medicine (Baltimore) | 2023 | 37773841 | PubTator, text mining | PubMed |
| Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies. | Front Pharmacol | 2023 | 37767404 | PubTator, text mining | PubMed |
| Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation. | Medicina (Kaunas) | 2023 | 37763758 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1629/papers?page=7